KH FEELUX BIOTECHNOLOGY

News

-COMPANY NOTICE-

News

Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer...: 2020.01.14

Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients

첨부파일 : Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.pdf

출처 : https://www.ncbi.nlm.nih.gov/pubmed/27853651

이전글 GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity

대장암 면역항암제 임상2상 진행 사항